Taro entered the North American market in 1984 through the acquisition of K-Line Pharmaceuticals Limited in Toronto, Canada. In 1988, Taro Pharmaceuticals U.S.A., Inc. established business operations in the U.S. to service an expanding base of customers. The 1990s were a decade of growth and achievement for Taro. Taro Research Institute Ltd. In 1992, Taro International Ltd. was founded to capitalize on increasing market opportunities around the world. In 1999, Taro received approval from the FDA for Warfarin Sodium Tablets, USP in all nine strengths.
Warfarin is an addition to Taro's increasing offering of solid dosage form products.
We are proud of how far we have come, and anticipate further growth in the exciting years ahead. Taro Pharmaceutical Industries Ltd. Please read our copyright and legal disclaimer . Web site designed by Brady Interactive .